In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends
Top Cited Papers
Open Access
- 5 April 2020
- journal article
- editorial
- Published by MDPI AG in Diagnostics
- Vol. 10 (4), 202
- https://doi.org/10.3390/diagnostics10040202
Abstract
There have been tremendous advances in in vitro diagnostic (IVD) assays for coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The main IVD assays used for COVID-19 employ real-time reverse transcriptase polymerase chain reaction (RT-PCR) that takes a few hours. But the assay duration has been shortened to 45 min by Cepheid. Of interest is the point-of-care (POC) molecular assay by Abbott that decreased the assay duration to just 5 min. Most molecular tests have been approved by the United States Food and Drug Administration (FDA) under emergency use authorization (EUA) and are Conformité Européenne (CE) marked. A wide range of serology immunoassays (IAs) have also been developed that complement the molecular assays for the diagnosis of COVID-19. The most prominent IAs are automated chemiluminescent IA (CLIA), manual ELISA, and rapid lateral flow IA (LFIA), which detect the immunoglobulin M (IgM) and immunoglobulin G (IgG) produced in persons in response to SARS-CoV-2 infection. The ongoing research efforts and advances in complementary technologies will pave the way to new POC IVD assays in the coming months. However, the performance of IVD assays needs to be critically evaluated before they are employed for the clinical diagnosis of COVID-19.Keywords
This publication has 15 references indexed in Scilit:
- Chest CT for Typical Coronavirus Disease 2019 (COVID-19) Pneumonia: Relationship to Negative RT-PCR TestingRadiology, 2020
- Presumed Asymptomatic Carrier Transmission of COVID-19JAMA, 2020
- Use of Chest CT in Combination with Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical SuspicionRadiology, 2020
- Molecular immune pathogenesis and diagnosis of COVID-19Journal of Pharmaceutical Analysis, 2020
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in GermanyThe New England Journal of Medicine, 2020
- The Novel Coronavirus Originating in Wuhan, ChinaJAMA, 2020
- Coronavirus Infections—More Than Just the Common ColdJAMA, 2020
- SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine DevelopmentPublished by Cold Spring Harbor Laboratory ,2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting WuhanEmerging Microbes & Infections, 2020